Synthetic Biologics, Inc. (NYSE: SYN) announced that following the completion of a previously planned interim analysis by an independent Interim ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE